Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
- First Posted Date
- 2006-02-13
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 30
- Registration Number
- NCT00291057
- Locations
- 🇺🇸
Investigator Site, Miamiville, Ohio, United States
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-10-26
- Last Posted Date
- 2013-12-23
- Lead Sponsor
- Taro Pharmaceuticals USA
- Target Recruit Count
- 360
- Registration Number
- NCT00244439
- Locations
- 🇺🇸
Investigator Site, Miamiville, Ohio, United States
© Copyright 2024. All Rights Reserved by MedPath